GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
7EW6 | S4Z1E9 | Barley photosystem I-LHCI-Lhca5 supercomplex | |
7F9O | S4Z1E9 | PSI-NDH supercomplex of Barley | |
7EWK | S4Z1E9 | Barley photosystem I-LHCI-Lhca6 supercomplex | |
7EW6 | S4Z1D9 | Barley photosystem I-LHCI-Lhca5 supercomplex | |
7F9O | S4Z1D9 | PSI-NDH supercomplex of Barley | |
7EWK | S4Z1D9 | Barley photosystem I-LHCI-Lhca6 supercomplex | |
7EW6 | S4YZ47 | Barley photosystem I-LHCI-Lhca5 supercomplex | |
7F9O | S4YZ47 | PSI-NDH supercomplex of Barley | |
6D7C | S4V1Z7 | The crystal structure of hemagglutinin from A/Hong Kong/61/2016 H7N9 influenza virus | |
1KTB | S43413 | The Structure of alpha-N-Acetylgalactosaminidase | |
1KTC | S43413 | The Structure of alpha-N-Acetylgalactosaminidase | |
5KN7 | S3TFW2 | Lipid A secondary acyltransferase LpxM from Acinetobacter baumannii | |
5KNK | S3TFW2 | Lipid A secondary acyltransferase LpxM from Acinetobacter baumannii with catalytic residue substitution (E127A) | |
1IGF | S38864 | CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS | |
2IGF | S38864 | CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS | |
1JLX | S24263 | AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE | |
8AKN | S1E9P3 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the terminating ribosome | |
8AM9 | S1E9P3 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the elongating ribosome | |
8ANA | S1E9P3 | Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit | |
1J8H | S18894 | Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide, and MHC Class II Molecule, HLA-DR4 | |
1CR7 | S14765 | PEANUT LECTIN-LACTOSE COMPLEX MONOCLINIC FORM | |
1MCO | S14675 | THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION | IMMUNOGLOBULIN G1 (IGG1) (MCG) WITH A HINGE DELETION |
3WCT | S0BCU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form | |
3WCU | S0BCU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form | |
3WCV | S0BCU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form | |
3WCW | S0BCU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: MG bound form | |
7VLC | S0BCU7 | Oxy-deoxy intermediate of V2 hemoglobin at 78% oxygen saturation | |
7VLD | S0BCU7 | Oxy-deoxy intermediate of V2 hemoglobin at 69% oxygen saturation | |
7VLE | S0BCU7 | Oxy-deoxy intermediate of V2 hemoglobin at 55% oxygen saturation | |
7VLF | S0BCU7 | Oxy-deoxy intermediate of V2 hemoglobin at 26% oxygen saturation | |
3WCT | S0BBU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form | |
3WCU | S0BBU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form | |
3WCV | S0BBU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form | |
3WCW | S0BBU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: MG bound form | |
7VLC | S0BBU7 | Oxy-deoxy intermediate of V2 hemoglobin at 78% oxygen saturation | |
7VLD | S0BBU7 | Oxy-deoxy intermediate of V2 hemoglobin at 69% oxygen saturation | |
7VLE | S0BBU7 | Oxy-deoxy intermediate of V2 hemoglobin at 55% oxygen saturation | |
7VLF | S0BBU7 | Oxy-deoxy intermediate of V2 hemoglobin at 26% oxygen saturation | |
3WCT | S0BBR6 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form | |
3WCU | S0BBR6 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form | |
3WCV | S0BBR6 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form | |
3WCW | S0BBR6 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: MG bound form | |
7VLC | S0BBR6 | Oxy-deoxy intermediate of V2 hemoglobin at 78% oxygen saturation | |
7VLD | S0BBR6 | Oxy-deoxy intermediate of V2 hemoglobin at 69% oxygen saturation | |
7VLE | S0BBR6 | Oxy-deoxy intermediate of V2 hemoglobin at 55% oxygen saturation | |
7VLF | S0BBR6 | Oxy-deoxy intermediate of V2 hemoglobin at 26% oxygen saturation | |
3WCT | S0BAP9 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form | |
3WCU | S0BAP9 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form | |
3WCV | S0BAP9 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form | |
3WCW | S0BAP9 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: MG bound form |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024